Anixa Biosciences is a clinical-stage biotechnology company developing vaccines and therapeutics for cancer and infectious disease. Lead programs include a breast cancer vaccine licensed from Cleveland Clinic and an ovarian cancer vaccine in collaboration with Moffitt Cancer Center.
Company Info
Upcoming Milestones & Key Dates
Phase 1 readout for breast cancer vaccine
Clinical Development Pipeline
Recent News
/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...
Leadership Team
Chairman, President & CEO
Chief Operating Officer & CFO
Chief Medical Officer
Careers & Job Openings